Clinical Trial Update: Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus [Phase 1]

View source ↗

Summary

Phase 1 trial update for polyclonal regulatory T cells (PolyTregs) in pemphigus shows terminated study with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Foliaceus
• Pemphigus Vulgaris

Drugs mentioned

• Polyclonal Regulatory T Cells (PolyTregs)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pemphigus Foliaceus, Pemphigus Vulgaris | Phase 1 | Status: TERMINATED | Results posted: 2021-11-22